Trial Profile
Phase III trial of becaplermin for diabetic foot ulcer treatment (US trial).
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 27 Apr 2012
Price :
$35
*
At a glance
- Drugs Becaplermin (Primary)
- Indications Diabetic foot ulcer
- Focus Registrational; Therapeutic Use
- 27 Apr 2012 New trial record